Share Twitter LinkedIn Facebook Email Jose F. Leis, MD, PhD, explains Venetoclax Rapidly Moving as Best 2nd-line Therapy SCT still remains as the only curative treatment Imedex Great Debates 2018.
Edetek’s CONFORM Platform: Streamlining Clinical Data Management in Oncology Trials General 3 Mins Read
High-Dose Chemotherapy for Recurrent Germ Cell Tumors: ASCO 2024 Study Results – Hedyeh Ebrahimi, MD – City of Hope ASCO Annual Meeting 2 Mins Read